Big changes ahead for Oregon’s psilocybin agency, New bill seeks to turn Trump’s psychedelics executive order into permanent law
Plus: Compass Pathways announces new Phase 3 results, and Lawsuit against LSD company Definium is dismissed
External link. We are not responsible for the content.
Read more ↗More From The Microdose (Berkeley)
What’s stopping psychedelic therapy in China? 5 Questions with medical ethicist Jennifer Docherty
Docherty discusses her interviews about psychedelic end-of-life care with clinicians in Hong Kong.
What is an “embedded” brain? Johnson & Johnson plans to invest in “neuroplastogen” company Delix; and University of Miami gifts Trump Administration accelerated path to research ibogaine
Plus: Oregon psilocybin program “generally safe,” according to new study, and New Mexico begins accepting psilocybin ...
What’s the difference between recreational and therapeutic psychedelic use? 5 Questions with experimental psychologist Harriet de Wit
De Wit discusses the difficulty of finding out what a drug does, outside of its context.
Latest News
MDMA and the FDA, Take Two
PLUS the Psychedelic Seeker's Guide, the World Ayahuasca Forum, and the best films to get trippy to. [...] Read More....
Global Altered States: Anytown, USA
This Week's Sunday Insider, Global Altered States: The Psychedelic Revolution is smaller than it looks.
Psychedelic Policy Briefing 8.21.26
Resilient Pharmaceuticals (formerly Lykos Therapeutics and MAPS PBC), reportedly resubmitted their once-rejected New ...
5 Psychedelic Stories You Should Know This Week
Welcome to The Psychedelic Blog. Bestselling essayist & Psychedelic cultural analyst examining how altered states sha...
Orchidaceaen Ethics 1
On acid, ancient philosophy, and the problem of knowing
Horizons: Perspectives on Psychedelics
Please join us this autumn for the 19th Horizons conference on October 15-17 in New York City. This is one of the imp...